4
Changes in Ownership
Arcutis Biotherapeutics, Inc. Filed Acc 0001628280-26-066331
Director sold 4,728 shares at $26.93 ($127,325)
- Director acquired 4,094 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Welgus Howard G. Director | 2026-10-15 | Option exercise 10b5-1 | +822 | $6.52 | $5,361 | 36,663 | D |
| Welgus Howard G. Director | 2026-10-15 | Option exercise 10b5-1 | +1,018 | $7.51 | $7,645 | 37,681 | D |
| Welgus Howard G. Director | 2026-10-15 | Option exercise 10b5-1 | +2,254 | $8.63 | $19,452 | 39,935 | D |
| Welgus Howard G. Director | 2026-10-15 | Sale 10b5-1 | −4,728 | $26.93 | $127,325 | 35,207 | D |
| Derivatives | |||||||
| Welgus Howard G. Director | 2026-10-15 | Option exercise · Stock Option (right to buy) 10b5-1 | −822 | 5,752 | D | ||
| Welgus Howard G. Director | 2026-10-15 | Option exercise · Stock Option (right to buy) 10b5-1 | −1,018 | 7,126 | D | ||
| Welgus Howard G. Director | 2026-10-15 | Option exercise · Stock Option (right to buy) 10b5-1 | −2,254 | 15,778 | D | ||
| Open-market sales · 4,728 sh · avg $26.93 · $127,325 | |||||||
Loading xslF345X06/wk-form4_1792442988.xml…